isis pharmaceuticals inc. Resources on BNET
On CNET: CBS to buy CNET Networks

BNET Industries

Isis Pharmaceuticals Inc. (ISIS) is in the Pharma Industry

Latest News and Analysis

Additional Resources

  • Incorporated: 1989
  • CEO: Dr. Stanley T. Crooke M.D., Ph

Isis Pharmaceuticals develops human therapeutic drugs using antisense technology. As of Dec 31 2007, Co. had two principal segments: Drug Discovery and Development, which is using a drug discovery platform to create a pipeline of drugs for its drug pipeline and its partners' drug pipelines designed to treat a variety of health conditions, including cardiovascular, metabolic, inflammatory, ocular and neurodegenerative diseases, and cancer with 18 drugs in development; and Ibis Biosciences, Inc., a majority-owned subsidiary, which developed and is commercializing its biosensor technology, including the Ibis T5000 Biosensor System and assay kits.

Key Competitors

advertisement
Isis Pharmaceuticals Inc. Company Info

Board of Directors

Dr. Stanley T. Crooke M.D., Ph

Chairman

Dr. Spencer R. Berthelsen

Ms. B. Lynne Parshall

Mr. Joseph H. Wender

Dr. Richard D. Dimarchi Ph.D.

Mr. Frederick T. Muto

Mr. Joseph Klein III

Dr. John C. Reed Ph.D.

Contact Information

1896 Rutherford Road

Carlsbad, CA

http://www.isispharm.com

760 931-9200

NAICS Code

Pharmaceutical Preparation Manufacturing: 325412
advertisement